1. Home
  2. FRST vs DMAC Comparison

FRST vs DMAC Comparison

Compare FRST & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRST
  • DMAC
  • Stock Information
  • Founded
  • FRST 2004
  • DMAC 2000
  • Country
  • FRST United States
  • DMAC United States
  • Employees
  • FRST N/A
  • DMAC N/A
  • Industry
  • FRST Major Banks
  • DMAC Biotechnology: Pharmaceutical Preparations
  • Sector
  • FRST Finance
  • DMAC Health Care
  • Exchange
  • FRST Nasdaq
  • DMAC Nasdaq
  • Market Cap
  • FRST 265.8M
  • DMAC 178.0M
  • IPO Year
  • FRST 2006
  • DMAC N/A
  • Fundamental
  • Price
  • FRST $11.17
  • DMAC $3.63
  • Analyst Decision
  • FRST Buy
  • DMAC Strong Buy
  • Analyst Count
  • FRST 1
  • DMAC 2
  • Target Price
  • FRST $420.00
  • DMAC $8.00
  • AVG Volume (30 Days)
  • FRST 86.4K
  • DMAC 326.6K
  • Earning Date
  • FRST 07-24-2025
  • DMAC 08-06-2025
  • Dividend Yield
  • FRST 3.54%
  • DMAC N/A
  • EPS Growth
  • FRST N/A
  • DMAC N/A
  • EPS
  • FRST 0.16
  • DMAC N/A
  • Revenue
  • FRST $125,133,000.00
  • DMAC N/A
  • Revenue This Year
  • FRST $21.33
  • DMAC N/A
  • Revenue Next Year
  • FRST $12.77
  • DMAC N/A
  • P/E Ratio
  • FRST $69.57
  • DMAC N/A
  • Revenue Growth
  • FRST 22.34
  • DMAC N/A
  • 52 Week Low
  • FRST $7.59
  • DMAC $3.00
  • 52 Week High
  • FRST $13.52
  • DMAC $6.82
  • Technical
  • Relative Strength Index (RSI)
  • FRST 71.92
  • DMAC 44.55
  • Support Level
  • FRST $10.40
  • DMAC $3.48
  • Resistance Level
  • FRST $11.41
  • DMAC $3.88
  • Average True Range (ATR)
  • FRST 0.25
  • DMAC 0.26
  • MACD
  • FRST 0.04
  • DMAC 0.00
  • Stochastic Oscillator
  • FRST 92.00
  • DMAC 30.10

About FRST Primis Financial Corp.

Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit. Its operating segments are Primis Mortgage, Primis Bank, and Other.

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main product candidate DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1, which is a synthetic version of the naturally occurring protease enzyme kallikrein-1 and a rhKLK1 undergoing clinical development studies in both AIS and PE. The other product candidate in the company's pipeline is DM300, its patented recombinant human ulinastatin, a broad-spectrum serine protease inhibitor, being developed as a potential therapy for severe acute pancreatitis.

Share on Social Networks: